Abstract
Glutamate receptors responding to N-methyl-d-aspartate (NMDA) are involved in neural development, excitotoxicity and neuronal plasticity. Each receptor includes at least two NR2 subunits. Here, we have examined the effects of selective antagonists of NR2A and NR2B subunits (NVP-AAM07 and Ro25-6981 respectively) on the effects of NMDA in the CA1 field of rat hippocampal slices. We have observed that Ro25-6981 potentiates, rather than blocks, the effects of NMD on field EPSPs and paired-pulse interactions (indicators of presynaptic effects) and on postsynaptic depolarisation in hippocampal slices. The NR2A subunit antagonist NVP-AAM077 blocks the effects of NMDA alone, or after potentiation by Ro25-6981. The potentiation of NMDA by Ro25-6981 was not prevented by staurosporine (protein kinase inhibitor), okadaic acid (an inhibitor of serine/threonine protein phosphatases) or anisomycin (protein synthesis inhibitor), but was prevented by cyclosporin A, which inhibits Ca2+/calmodulin-dependent phosphatase 2B [calcineurin]. NMDA-dependent long-term potentiation (LTP) induced by electrical stimulation was not prevented by Ro25-6981 but was prevented by selective blockade of the NR2A subunit. The results suggest that, at both presynaptic and postsynaptic sites in the rat hippocampus, NR2B-subunit-containing receptors limit NMDA receptor function by inhibitory restraint over NR2A-subunit-containing receptors, via calcineurin activation, and that LTP induction critically involves primarily receptors containing the NR2A subunit. Endogenous factors or drugs that modify this NR2B/NR2A interaction could have a major influence on synaptic transmission and plasticity in the brain.
Similar content being viewed by others
References
Auberson YP, Allgeier H, Bischoff S, Lingenhoehl K, Moretti R, Schmutz M (2002) 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg Med Chem Lett 12:1099–1102
Bartrup JT, Stone TW (1990) Activation of NMDA receptor-coupled channels suppresses the inhibitory action of adenosine on hippocampal slices. Brain Res 530:330–334
Behan DP, Chalmers DT (2001) The use of constitutively active receptors for drug discovery at the G protein-coupled receptor gene pool. Curr Opin Drug Discov Dev 4:548–560
Bialojan C, Takai A (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 25:283–290
Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31–39
Cai N, Kiss B, Erdo L (1991) Heterogeneity of NMDA receptors regulating the release of dopamine and acetylcholine from striatal slices. J Neurochem 57:2148–2151
Chen NS, Luo T, Wellington C, Metzler M, McCutcheon K, Hayden MR, Raymond LA (1999) Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem 72:1890–1898
Cheng C, Fass DM, Reynolds IJ (1999) Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)](i) increases and NMDA receptor mRNA levels. Brain Res 849:97–108
Chizh BA, Headley PM, Tzschentke TM (2001) NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci 22:636–642
Ferrer-Montiel AV, Montal M (1996) Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc Natl Acad Sci USA 93:2741–2744
Fink K, Bonisch H, Gothert M (1990). Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur J Pharmacol 185:115–117
Fischer G, Mutel V, Trube G, Malherbe P, Kew JN, Mohacsi E, Heitz MP, Kemp JA (1997) Ro 25–6981, a highly potent and selective blocker of N-methyl-d-aspartate receptors containing the NR2B subunit. Characterization in vitro. J Pharmacol Exp Ther 283:1285–1292
Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA (2000) Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiat 157:1141–1149
Gill R, Alanine A, Bourson A, Buttelmann B, Fischer G, Heitz MP, Kew JN, Levet Trafit B, Lorez HP, Malherbe P, Miss MT, Mutel V, Pinard E, Roever S, Schmitt M, Trube G, Wybrecht R, Wyler R, Kemp JA (2002) Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-d-aspartate antagonist. J Pharmacol Exp Ther 302:940–948
Grollman AP (1967) Inhibitors of protein biosynthesis. II. Mode of action of anisomycin. J Biol Chem 242:3226–3233
Grosshans DR, Clayton DA, Coultrap SJ, Browning MD (2002) LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nature Neurosci 5:27–33
Higgins MJ, Stone TW (1996) The contribution of adenosine to paired-pulse inhibition in the normal and disinhibited hippocampal slice. Eur J Pharmacol 317:215–223
Hrabetova S, Serrano P, Blace N, Tse HW, Skifter DA, Jane DE, Monaghan DT, Sacktor TC (2000) Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. J Neurosci 20:RC81
Kato K, Zorumski CF (1999) Modulation of long-term potentiation in the hippocampus by NMDA-mediated presynaptic inhibition. Neuroscience 92:1261–1272
Kew JNC, Trube G, Kemp JA (1996) A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 497:761–772
Laube B, Hirai H, Sturgess M, Betz H, Kuhse J (1997) Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 18:493–503
Laube B, Kuhse J, Betz H (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J Neurosci 18:2954–2961
Liu LD, Wong TP, Pozza MF, Lingenhoehl K, Wang YS, Sheng M, Auberson YP, Wang YT (2004) Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304:1021–1024
Lynch DR, Shim SS, Seifert KM, Kurapathi S, Mutel V, Gallagher MJ, Guttmann RP (2001) Pharmacological characterization of interactions of RO25-6981 with the NR2B ([epsilon]2) subunit. Eur J Pharmacol 416:185–195
Mano I, Teichberg VI (1998) A tetrameric subunit stoichiometry for a glutamate receptor-channel complex. Neuroreport 9:327–331
Martin D, Bustos GA, Bowe MA, Bray SD, Nadler JV (1991) Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area. J Neurochem 56:1647–1655
Mutel V, Buchy D, Klingelschmidt A, Messer J, Bleuel Z, Kemp JA, Richards JG (1998) In vitro binding properties in rat brain of [3H]Ro25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem 70:2147–2155
Nikbakht MR, Stone TW (2001) Suppression of presynaptic responses to adenosine by activation of NMDA receptors. Eur J Pharmacol 427:13–25
Overton P, Clark D (1991) NMDA increases the excitability of nigrostriatal dopamine terminals. Eur J Pharmacol 201:117–120
Premkumar LS, Auerbach A (1997) Stoichiometry of recombinant N-methyl-d-aspartate receptor channels inferred from single-channel current patterns. J Gen Physiol 110:485–502
Richard F, Barroso S, Martinez J, Labbe Jullie C, Kitabgi P (2001) Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol Pharmacol 60:1392–1398
Rosenmund C, Stern-Bach Y, Stevens CF (1998) The tetrameric structure of a glutamate receptor channel. Science 280:1596–1599
Rusakov DA, Scimemi A, Walker MC, Kullmann DM (2004) Comment on the role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 305:1912b
Rycroft BK, Gibb AJ (2002) Direct effects of calmodulin on NMDA receptor single-channel gating in rat hippocampal granule cells. J Neurosci 22:8860–8868
Scheer A, Cotecchia S (1997) Constitutively active G protein-coupled receptors: potential mechanisms of receptor activation. J Recept Signal Tr R 17:57–73
Schurr A, Payne RS, Heine MF, Rigor BM (1995) Hypoxia, excitotoxicity, and neuroprotection in the hippocampal slice preparation. J Neurosci Meth 59:129–138
Shahraki A, Stone TW (2003) Interactions between adenosine and metabotropic receptors in the rat hippocampal slice. Brit J Pharmacol 138:1059–1068
Steece-Collier K, Chambers LK, Jaw-Tsai S S, Menniti FS, Greenamyre JT (2000) Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors. Exp Neurol 163:239–243
Wilcox KS, Dichter MA (1994) Paired-pulse depression in cultured hippocampal neurons is due to a presynaptic mechanism independent of GABA-B autoreceptor activation. J Neurosci 14:1775–1788
Wong TP, Liu LD, Sheng M, Wang YT (2004) Response to comment on the role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 305:1912c
Woodhall G, Evans DI, Cunningham MO, Jones RS (2001) NR2B-containing NMDA autoreceptors at synapses on entorhinal cortical neurons. J Neurophysiol 86:1644–1651
Wu LG, Saggau P (1994) Presynaptic Ca2+ is increased during normal synaptic transmission and paired-pulse facilitation but not long-term potentiation in area CA1 of hippocampus. J Neurosci 14:645–654
Zhang L, Hsu JC, Takagi N, Gurd JW, Wallace MC, Eubanks JH (1997) Transient global ischemia alters NMDA receptor expression in rat hippocampus: correlation with decreased immunoreactive protein levels of the NR2A/2B subunits, and an altered NMDA receptor functionality. J Neurochem 69:1983–1994
Acknowledgements
We are grateful to Dr. Y. Auberson of Novartis Pharmaceuticals for the gift of NVP-AAM077.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mallon, A.P., Auberson, Y.P. & Stone, T.W. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-d-aspartate receptors in hippocampal slices. Exp Brain Res 162, 374–383 (2005). https://doi.org/10.1007/s00221-004-2193-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-004-2193-6